{"id":"https://openalex.org/W2020733906","doi":"https://doi.org/10.1111/ane.12171","title":"OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program","display_name":"OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program","alternate_titles":[],"publication_year":2013,"publication_date":"2013-09-20","ids":{"openalex":"https://openalex.org/W2020733906","doi":"https://doi.org/10.1111/ane.12171","mag":"2020733906","pmid":"https://pubmed.ncbi.nlm.nih.gov/24107267","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4033567"},"language":"en","primary_location":{"id":"doi:10.1111/ane.12171","doi":"https://doi.org/10.1111/ane.12171","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ane.12171","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ane.12171","source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2020733906"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ane.12171","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103077601","display_name":"Sheena K. Aurora","orcid":"https://orcid.org/0000-0002-9425-1710","observed_orcids":["https://orcid.org/0000-0002-9425-1710","https://orcid.org/0000-0002-4534-4937"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"S. K. Aurora","raw_affiliation_strings":["Stanford University, Stanford, CA, USA","S. K. Aurora, Department of Neurology & Neurological Sciences, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA","Tel.: (650) 723-5184"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University, Stanford, CA, USA","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"S. K. Aurora, Department of Neurology & Neurological Sciences, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA","institution_ids":["https://openalex.org/I97018004"]},{"raw_affiliation_string":"Tel.: (650) 723-5184","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057290642","display_name":"David W. Dodick","orcid":"https://orcid.org/0000-0002-9486-6790","observed_orcids":["https://orcid.org/0000-0002-9486-6790"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. W. Dodick","raw_affiliation_strings":["Mayo Clinic Arizona, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114018595","display_name":"HC Diener","orcid":"https://orcid.org/0000-0002-6556-8612","observed_orcids":["https://orcid.org/0000-0002-6556-8612"]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"H.\u2010C. Diener","raw_affiliation_strings":["University of Essen, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Essen, Essen, Germany","institution_ids":["https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109943334","display_name":"Ronald E. DeGryse","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. E. DeGryse","raw_affiliation_strings":["Allergan, Inc., Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan, Inc., Irvine, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109918667","display_name":"Catherine C. Turkel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. C. Turkel","raw_affiliation_strings":["Allergan, Inc., Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergan, Inc., Irvine, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000448269","display_name":"Richard B. Lipton","orcid":"https://orcid.org/0000-0003-2652-2897","observed_orcids":["https://orcid.org/0000-0003-2652-2897"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. B. Lipton","raw_affiliation_strings":["Albert Einstein College of Medicine, Bronx, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine, Bronx, NY, USA","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108076630","display_name":"Stephen David Silberstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. D. Silberstein","raw_affiliation_strings":["Thomas Jefferson University, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomas Jefferson University, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I149251103"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5103077601"],"corresponding_institution_ids":["https://openalex.org/I97018004"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":7.1221,"has_fulltext":true,"cited_by_count":183,"citation_normalized_percentile":{"value":0.9782104,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"129","issue":"1","first_page":"61","last_page":"70"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10852","display_name":"Temporomandibular Joint Disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3504","display_name":"Oral Surgery"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/onabotulinumtoxina","display_name":"onabotulinumtoxinA","score":0.9200000166893005},{"id":"https://openalex.org/keywords/chronic-migraine","display_name":"chronic migraine","score":0.9679999947547913},{"id":"https://openalex.org/keywords/migraine-prevention","display_name":"migraine prophylaxis","score":0.8970000147819519},{"id":"https://openalex.org/keywords/preempt-trial","display_name":"PREEMPT trial","score":0.7289999723434448},{"id":"https://openalex.org/keywords/headache-frequency","display_name":"headache frequency","score":0.5509999990463257},{"id":"https://openalex.org/keywords/migraine-days","display_name":"migraine days","score":0.6520000100135803},{"id":"https://openalex.org/keywords/hit-6","display_name":"HIT-6","score":0.7459999918937683},{"id":"https://openalex.org/keywords/migraine-specific-quality-of-life","display_name":"migraine-specific quality of life","score":0.8379999995231628},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.527999997138977},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6919999718666077},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.5199999809265137},{"id":"https://openalex.org/keywords/placebo-response","display_name":"placebo response","score":0.3580000102519989},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.421999990940094}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8673834800720215},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8422129154205322},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7266300916671753},{"id":"https://openalex.org/C2780966972","wikidata":"https://www.wikidata.org/wiki/Q86","display_name":"Headaches","level":2,"score":0.7232655882835388},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.7217985391616821},{"id":"https://openalex.org/C2910587157","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Chronic Migraine","level":3,"score":0.6018867492675781},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5131691098213196},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4706422686576843},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4648061990737915},{"id":"https://openalex.org/C2780084366","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demographics","level":2,"score":0.46134430170059204},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4386252760887146},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2806239128112793},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001763","descriptor_name":"Blepharoptosis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018908","descriptor_name":"Muscle Weakness","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D019274","descriptor_name":"Botulinum Toxins, Type A","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019274","descriptor_name":"Botulinum Toxins, Type A","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019274","descriptor_name":"Botulinum Toxins, Type A","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/ane.12171","doi":"https://doi.org/10.1111/ane.12171","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ane.12171","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ane.12171","source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3018098","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4033567","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24107267","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24107267","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta neurologica Scandinavica","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:pubmedcentral.nih.gov:4033567","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4033567/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurol Scand","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/ane.12171","doi":"https://doi.org/10.1111/ane.12171","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ane.12171","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ane.12171","source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1457003177","display_name":"Gender and Hormonal Differences in Parkinson's Disease","funder_award_id":"K23NS047256","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G3572745015","display_name":"Biomarkers in Early Alzheimer's Disease (AD).","funder_award_id":"R01AG022374","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G3806763781","display_name":"Role of Genes in Exceptional Longevity in Humans","funder_award_id":"P01AG027734","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G4033720201","display_name":"Einstein Aging Study","funder_award_id":"P01AG003949","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G4148470331","display_name":null,"funder_award_id":"AG025119","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G4508791442","display_name":"TWO PRECLINICAL LATENT SCORES  TO PREDICT OCCURRENCE OF DAT","funder_award_id":"R01AG034119","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G5599001628","display_name":"MRI Progression Markers of Cognitive Decline in the Elderly","funder_award_id":"R01AG012101","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G5902036982","display_name":"Optimizing the Emergency Department diagnosis and treatment of migraines","funder_award_id":"K23NS051409","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G7059695791","display_name":"Predictors of Gait and Falls in Aging: Linking Cognitive Control to Genes","funder_award_id":"K23AG030857","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G7512173784","display_name":"Latent Mobility Abnormalities And Frailty","funder_award_id":"R01AG025119","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G8784440921","display_name":null,"funder_award_id":"K23NS05140901A1","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309147","display_name":"eNeura Therapeutics","ror":"https://ror.org/013w40a11"},{"id":"https://openalex.org/F4320310567","display_name":"Boston Scientific Corporation","ror":"https://ror.org/0385es521"},{"id":"https://openalex.org/F4320313767","display_name":"Zogenix","ror":"https://ror.org/03ynh3q24"},{"id":"https://openalex.org/F4320314128","display_name":"Les Laboratories Pierre Fabre","ror":"https://ror.org/04hdhz511"},{"id":"https://openalex.org/F4320315343","display_name":"American Headache Society","ror":"https://ror.org/00vq6eh39"},{"id":"https://openalex.org/F4320320273","display_name":"University of Cambridge","ror":"https://ror.org/013meh722"},{"id":"https://openalex.org/F4320320290","display_name":"University of Oxford","ror":"https://ror.org/052gg0110"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"},{"id":"https://openalex.org/F4320321114","display_name":"Bundesministerium f\u00fcr Bildung und Forschung","ror":"https://ror.org/04pz7b180"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332389","display_name":"St. Jude Medical","ror":"https://ror.org/00t9de449"},{"id":"https://openalex.org/F4320332585","display_name":"Allergan","ror":"https://ror.org/00wthd003"},{"id":"https://openalex.org/F4320333874","display_name":"Bayer Vital","ror":null},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"},{"id":"https://openalex.org/F4320338413","display_name":"Cilag","ror":"https://ror.org/02fe4h741"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2020733906.pdf","grobid_xml":"https://content.openalex.org/works/W2020733906.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W204766049","https://openalex.org/W1703283460","https://openalex.org/W1726943434","https://openalex.org/W1994481205","https://openalex.org/W2002101128","https://openalex.org/W2007410119","https://openalex.org/W2014074875","https://openalex.org/W2019197300","https://openalex.org/W2020791529","https://openalex.org/W2032593044","https://openalex.org/W2032666115","https://openalex.org/W2086980566","https://openalex.org/W2095583476","https://openalex.org/W2098215775","https://openalex.org/W2108490520","https://openalex.org/W2115337076","https://openalex.org/W2137434212","https://openalex.org/W2141239193","https://openalex.org/W2142670324","https://openalex.org/W2152526535","https://openalex.org/W2158846562","https://openalex.org/W2160202859","https://openalex.org/W2167719770","https://openalex.org/W2170860462","https://openalex.org/W3022218734","https://openalex.org/W4230120862","https://openalex.org/W4230690466","https://openalex.org/W4246003883","https://openalex.org/W4247292047"],"related_works":["https://openalex.org/W2007410119","https://openalex.org/W2167719770","https://openalex.org/W1994481205","https://openalex.org/W1996747736","https://openalex.org/W4230120862","https://openalex.org/W1995770977","https://openalex.org/W2337537538","https://openalex.org/W4399922669","https://openalex.org/W2143744763","https://openalex.org/W2944960716"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Chronic":[1],"migraine":[2,210],"(CM)":[3],"is":[4],"a":[5,87,276],"prevalent":[6],"and":[7,23,47,74,144,219,244,253,256,320,357,377,387,393],"disabling":[8],"neurological":[9],"disorder.":[10],"Phase":[11],"III":[12,57],"REsearch":[13],"Evaluating":[14],"Migraine":[15],"Prophylaxis":[16],"Therapy":[17],"(PREEMPT)":[18],"clinical":[19],"program":[20],"assessed":[21,39],"efficacy":[22,73],"safety":[24,75],"of":[25,30,76,122,149,154,200,235,241,259,273,283],"onabotulinumtoxinA":[26,77,94,105,140,155,311,326,342,367],"(BOTOX(\u00ae))":[27],"for":[28,100,106,116,187,289,310,314,322,327,352,391],"prophylaxis":[29],"headaches":[31],"in":[32,78,198,281,316],"adults":[33],"with":[34,82,172,246,275,325,341,366,382],"CM.":[35],"This":[36,336],"secondary":[37],"analysis":[38,338],"patients":[40,123,169,274,323,363],"who":[41],"received":[42,133,139,146],"all":[43,134,168,328],"five":[44,135,329],"treatment":[45,136,162,343],"cycles":[46,137,148,153,330],"completed":[48],"the":[49,72,117,182,188,290,317,332,374],"study.":[50],"MATERIALS":[51],"AND":[52],"METHODS:":[53],"PREEMPT":[54,130],"(two":[55,348],"phase":[56,319],"studies:":[58],"24-week":[59],"double-blind,":[60],"placebo-controlled":[61],"[DBPC],":[62],"parallel-group":[63],"phase,":[64],"followed":[65,103],"by":[66,104],"32-week":[67],"open-label":[68],"[OL]":[69],"phase)":[70],"evaluated":[71],"CM":[79],"(\u226515":[80],"days/month":[81],"headache":[83,110,190,201,221,236,238,242,284,354],"lasting":[84],"\u22654":[85],"h":[86],"day).":[88],"Patients":[89],"were":[90,113,159,170,264],"randomized":[91],"(1:1)":[92],"to":[93,176],"or":[95],"placebo":[96,150,315,347],"every":[97],"12":[98],"weeks":[99],"two":[101,147],"cycles,":[102],"three":[107,152],"cycles.":[108],"Multiple":[109],"symptom":[111,191,355],"measures":[112,232,356],"evaluated.":[114],"Results":[115],"completer":[118],"(five":[119,344],"cycles)":[120,345,351],"subgroup":[121,337],"are":[124],"reported.":[125],"RESULTS:":[126],"Of":[127],"1384":[128],"total":[129,254],"patients,":[131],"1005":[132],"(513":[138],"only":[141],"[onabotulinumtoxinA/onabotulinumtoxinA":[142],"(O/O)]":[143],"492":[145],"then":[151],"[placebo/onabotulinumtoxinA":[156],"(P/O)]).":[157],"Demographics":[158],"similar":[160],"between":[161],"groups.":[163],"At":[164],"Week":[165,294,361],"56,":[166,362],"after":[167],"treated":[171,324,364],"onabotulinumtoxinA,":[173],"there":[174,263],"continued":[175,375,383],"be":[177],"significant":[178],"between-group":[179],"differences":[180],"favoring":[181],"O/O":[183],"vs":[184,312,346],"P/O":[185],"group":[186,292],"following":[189],"measures:":[192],"LS":[193],"mean":[194,267],"change":[195],"from":[196,269,279],"baseline":[197,280],"frequencies":[199],"days":[202,211,222,285],"(-12.0":[203],"O/O,":[204,213,224,297],"-11.1":[205],"P/O;":[206,215,226,299],"P":[207,216,227,300],"=":[208,217,228,301],"0.035),":[209],"(-11.6":[212],"-10.7":[214],"0.038),":[218],"moderate/severe":[220],"(-11.0":[223],"-10.1":[225],"0.042).":[229],"For":[230],"other":[231],"(cumulative":[233],"hours":[234],"on":[237],"days,":[239],"frequency":[240,282],"episodes,":[243],"percentage":[245],"severe":[247],"Headache":[248],"Impact":[249],"Test":[250],"(HIT)-6":[251],"score,":[252],"HIT-6":[255],"Migraine-Specific":[257],"Quality":[258],"Life":[260],"Questionnaire":[261],"scores),":[262],"also":[265],"large":[266],"improvements":[268,340],"baseline.":[270],"The":[271,303],"percent":[272],"\u226550%":[277],"reduction":[278],"was":[286,308],"significantly":[287],"greater":[288],"onabotulinumtoxinA-only":[291],"at":[293,360],"56":[295],"(69.6%":[296],"62.8%":[298],"0.023).":[302],"treatment-related":[304],"adverse":[305],"event":[306],"rate":[307],"28.5%":[309],"12.4%":[313],"DBPC":[318],"34.8%":[321],"throughout":[331],"56-week":[333],"trials.":[334],"CONCLUSIONS:":[335],"demonstrated":[339],"cycles)/onabotulinumtoxinA":[349],"(three":[350],"multiple":[353],"suggests":[358],"that":[359],"earlier":[365],"had":[368],"better":[369],"outcomes.":[370],"These":[371],"findings":[372],"demonstrate":[373],"need":[376],"cumulative":[378],"benefit":[379],"over":[380],"time":[381],"prophylaxis,":[384],"an":[385],"important":[386],"clinically":[388],"pragmatic":[389],"observation":[390],"clinicians":[392],"patients.":[394]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2020733906","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":15},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
